Comparative Enzyme Kinetic Analysis of the Launched DPP-4 Inhibitors

被引：0
|
作者：
Schnapp, Gisela
Klein, Thomas
Mark, Michael
Fuchs, Holger
Bakker, Remko A.
Nar, Herbert
机构：
来源：
DIABETES | 2014年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1048-P
引用
收藏
页码：A271 / A271
页数：1
相关论文
共 50 条
  • [41] Medicinal Chemistry of Incretin Mimetics and DPP-4 Inhibitors
    Zettl, Heiko
    Schubert-Zsilavecz, Manfred
    Steinhilber, Dieter
    CHEMMEDCHEM, 2010, 5 (02) : 179 - 185
  • [42] DPP-4 Inhibitors-Renoprotection in Diabetic Nephropathy?
    Panchapakesan, Usha
    Pollock, Carol A.
    DIABETES, 2014, 63 (06) : 1829 - 1830
  • [43] DPP-4 inhibitors: a new class of oral antidiabetics
    Gallwitz, B.
    DIABETES STOFFWECHSEL UND HERZ, 2007, 16 (01): : 43 - 50
  • [44] DPP-4 inhibitors: pharmacological differences and their clinical implications
    Ceriello, Antonio
    Sportiello, Liberata
    Rafaniello, Concetta
    Rossi, Francesco
    EXPERT OPINION ON DRUG SAFETY, 2014, 13 : S57 - S68
  • [45] The physiology of incretin hormones and the basis for DPP-4 Inhibitors
    McKennon, Skye Aiko
    Campbell, R. Keith
    DIABETES EDUCATOR, 2007, 33 (01): : 55 - +
  • [46] Case study DPP-4 Inhibitors and Insulin in Combination
    Holstein, Andreas
    DIABETES STOFFWECHSEL UND HERZ, 2012, 21 (03): : 165 - 170
  • [47] DPP-4 inhibitors associated with acute kidney injury
    Reactions Weekly, 2016, 1605 (1) : 8 - 8
  • [48] Alogliptin: a new addition to the class of DPP-4 inhibitors
    Andukuri, Radha
    Drincic, Andjela
    Rendell, Marc
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2009, 2 : 117 - 126
  • [49] DPP-4 inhibitors have differing AE trends
    Reactions Weekly, 2023, 1940 (1) : 9 - 9
  • [50] DPP-4 inhibitors: What may be the clinical differentiators?
    Gerich, John
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 90 (02) : 131 - 140
12345